1,159 results on '"Calvert, Melanie"'
Search Results
2. Author Correction: Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines
3. Predictors of quality of life, functional status, depression and fatigue in early arthritis: comparison between clinically suspect arthralgia, unclassified arthritis and rheumatoid arthritis
4. Concordance of randomised controlled trials for artificial intelligence interventions with the CONSORT-AI reporting guidelines
5. Recommendations to address respondent burden associated with patient-reported outcome assessment
6. A framework for implementing patient-reported outcomes in clinical care: the PROTEUS-practice guide
7. A toolkit for capturing a representative and equitable sample in health research
8. The value of standards for health datasets in artificial intelligence-based applications
9. Evaluating patient-reported outcome measures (PROMs) for future clinical trials in adult patients with optic neuritis
10. Considerations for patient and public involvement and engagement in health research
11. The cost of primary care consultations associated with long COVID in non-hospitalised adults: a retrospective cohort study using UK primary care data
12. Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
13. “I just wanted to speak to someone- and there was no one…”: using Burden of Treatment Theory to understand the impact of a novel ATMP on early recipients
14. Co-production of a feasibility trial of pacing interventions for Long COVID
15. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension/Directrices para los protocolos de ensayos clinicos de intervenciones con inteligencia artificial: la extension SPIRIT-AI/Diretrizes para protocolos de ensaios clinicos com intervencoes que utilizam inteligencia artificial: a extensao SPIRIT-AI
16. SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials.
17. Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study
18. The effect of disease modifying therapies on fatigue in multiple sclerosis
19. Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials
20. Patient and public involvement within epidemiological studies of long COVID in the UK
21. Paving the way for patient centricity in real-world evidence (RWE): Qualitative interviews to identify considerations for wider implementation of patient-reported outcomes in RWE generation
22. Identifying patient-valued outcomes for use in early phase trials of ocular surface disease interventions
23. Optimising the selection of outcomes for healthy ageing trials: a mixed methods study
24. Knowledge translation concerns for the CONSORT-PRO extension reporting guidance: a review of reviews
25. Disruptions to the hearing health sector
26. Usability testing of an electronic patient-reported outcome system linked to an electronic chemotherapy prescribing and patient management system for patients with cancer
27. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
28. Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
29. The Role of Patient-Reported Outcomes (PROs) in the Improvement of Healthcare Delivery and Service
30. Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group
31. Symptoms and risk factors for long COVID in non-hospitalized adults
32. Opportunities and Risks of UK Medical Device Reform
33. Views and experience of non-hospitalised individuals with Long COVID of using pacing interventions: a mixed methods study
34. Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
35. Patient reported outcome assessment must be inclusive and equitable
36. The opportunity for greater patient and public involvement and engagement in drug development and regulation
37. Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999–2021)
38. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study
39. Understanding and tracking the impact of long COVID in the United Kingdom
40. Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection
41. Systematic review of guidance for the collection and use of patient-reported outcomes in real-world evidence generation to support regulation, reimbursement and health policy
42. Evaluating patient-reported outcome measures (PROMs) for clinical trials and clinical practice in adult patients with uveitis or scleritis: a systematic review
43. Factors influencing follow-up care post-TIA and minor stroke: a qualitative study using the theoretical domains framework
44. Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance
45. Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
46. Integrating patient and public involvement and engagement in translational medicine.
47. Collaborative care intervention for individuals with severe mental illness: the PARTNERS2 programme including complex intervention development and cluster RCT.
48. Patient-reported outcomes in integrated health and social care: A scoping review
49. Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study)
50. [Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given the estimand framework
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.